BATS BZX Real-Time Price
As of 2:00pm ET
| +0.60 / +2.01%|
The 14 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 39.00, with a high estimate of 56.00 and a low estimate of 30.00. The median estimate represents a +28.08% increase from the last price of 30.45.
The current consensus among 14 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.